Bayer’s market capitalization has shrunk over 40% since it closed the Monsanto deal a year ago, as investors worry about liabilities from Monsanto’s allegedly carcinogenic weedkiller Roundup
BERLIN—Stuck in one of the worst crises in its 155-year history, Bayer AG, the German company that invented aspirin and owns a team playing in the country’s top soccer league, is worth less today than the $63 billion it paid for Monsanto Co.
Bayer’s market capitalization has shrunk over 40% since it closed the Monsanto deal a year ago to roughly €53 billion. Investors are increasingly abandoning the stock: They are worried that Bayer’s liabilities from Monsanto’s allegedly carcinogenic weedkiller Roundup are only going to...
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
California jury says Bayer must pay $2 billion to couple in Roundup cancer trialJUST IN: California jury awards more than $2 billion to couple who claimed Bayer's glyphosate-based Roundup weed killer caused their cancer by TinaBellon
Weiterlesen »
In Latest Roundup Herbicide Defeat for Bayer, Jury Awards California Couple $2 BillionBayer faced its third courtroom defeat from a lawsuit alleging Roundup weedkiller led to cancer, with a California jury awarding a couple $2.055 billion in damages.
Weiterlesen »
Bayer to pay $2 billion after losing suit that claims weedkiller Roundup causes cancerBayer AG on Monday was ordered by a California jury to pay $2 billion to a couple who say they were diagnosed with cancer after using the company's weedkiller Roundup.
Weiterlesen »
California jury awards couple $2 billion in latest Roundup herbicide defeat for BayerA jury dealt Bayer AG a third court defeat, awarding $2.055 billion to a California couple who blamed the German company’s Roundup weedkiller for causing...
Weiterlesen »
California jury hits Bayer with $2 billion award in Roundup cancer trialA California jury on Monday awarded more than $2 billion to a couple who claimed...
Weiterlesen »
Bayer stock at lowest in nearly seven years after $2 billion award in Roundup trialShares in Bayer were down 5.9 percent in early trade on Tuesday after a jury awa...
Weiterlesen »
Bayer Shares Fall After $2 Billion Roundup VerdictBayer shares resumed their monthslong fall after the company was hit by a more-than $2 billion jury award over its Roundup herbicide, marking a sharp escalation in the chemical and drug giant’s legal woes.
Weiterlesen »
Bayer stock continues rout after $2 billion award in Roundup trialShares in Bayer fell as much as 5 percent on Tuesday after a jury awarded more t...
Weiterlesen »
Bayer nears seven-year low after $2 billion award in Roundup trialBayer nears seven-year low after California couple awarded $2 billion in Roundup trial via LudwigBurger
Weiterlesen »
Factbox: More Roundup trials, appeals in store for Bayer after $2 billion verdictBayer shares continued to fall on Tuesday after a California jury on Monday awar...
Weiterlesen »
Bayer bets on 'silver bullet' defense in Roundup litigation; experts see hurdlesBayer AG plans to argue that a $2 billion jury award and thousands of U.S. lawsu...
Weiterlesen »